HER2 Support Group Forums - View Single Post

R.B. · 05-22-2006, 01:50 AM

Fairly vague I 'm afraid and you will have to check for yourself but I have a recollection of reading that CoQ10 benifitedpersons with periodontal problems.

PGE2 is linked to periodontal problems. Cox 2 is a percussor of PGE 2.

RB

http://www.ncbi.nlm.nih.gov/entrez/q...=pubmed_docsum

There is limited suggestion DHA may help

http://www.ncbi.nlm.nih.gov/entrez/q...=pubmed_docsum

1: Bull Group Int Rech Sci Stomatol Odontol. 1996 Feb-Mar;39(1-2):25-31. Related Articles, Links

[Polyunsaturated omega-3 fatty acids in the treatment of experimental human gingivitis]

[Article in French]

Campan P, Planchand PO, Duran D.

Departement de Chirurgie Buccale, U.F.R. d'Odontologie, Toulouse, France.

The anti-inflammatory effect of omega-3 polyunsaturated fatty acids (n-3 PUFA) has already been demonstrated in an animal model. The aim of this randomized, double-blind, versus placebo study is to assess this action on experimental gingivitis in humans. Over a 14-day period (day 0-day 14), 37 healthy volunteers undertook intensive oral hygiene, and then did not brush their teeth for 21 days (day 14-day 35) so that gingivitis could then develop. On day 28, the subjects were randomized in two groups: 18 in the treatment group (fish oil: 1.8 g of n-3 PUFA), 19 in the placebo group (olive oil), at a daily dose of 6 g over days (day 28-day 35). The Plaque Index (PI), the Gingival Index (GI) and the Papilla Bleeding Index (PBI), as inflammation markers, were measured on day 14, day 28 and day 35. On day 28 and day 35, five volunteers of each group underwent removal of an interdental papilla to carry out the n-3 PUFA composition of cell membranes: arachidonic acid (AA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), docosahexaenoic acid (DHA). The results show the integration of EPA, DHA and DPA in the membranes of the cells removed and particularly a significant increase of EPA in the treatment group (p = 0.04 S). GI in the treatment group decreased significantly (p = 0.008 S). The level of AA decrease, but no significantly. It would therefore seem that the n-3 PUFA have an effect on the reduction of gingival inflammation in this experimental gingival model in humans.

Publication Types:

* Clinical Trial
* Randomized Controlled Trial

PMID: 8720373 [PubMed - indexed for MEDLINE]

05-22-2006, 01:50 AM	#5
R.B. Senior Member Join Date: Mar 2006 Posts: 1,843	Fairly vague I 'm afraid and you will have to check for yourself but I have a recollection of reading that CoQ10 benifitedpersons with periodontal problems. PGE2 is linked to periodontal problems. Cox 2 is a percussor of PGE 2. RB http://www.ncbi.nlm.nih.gov/entrez/q...=pubmed_docsum There is limited suggestion DHA may help http://www.ncbi.nlm.nih.gov/entrez/q...=pubmed_docsum 1: Bull Group Int Rech Sci Stomatol Odontol. 1996 Feb-Mar;39(1-2):25-31. Related Articles, Links [Polyunsaturated omega-3 fatty acids in the treatment of experimental human gingivitis] [Article in French] Campan P, Planchand PO, Duran D. Departement de Chirurgie Buccale, U.F.R. d'Odontologie, Toulouse, France. The anti-inflammatory effect of omega-3 polyunsaturated fatty acids (n-3 PUFA) has already been demonstrated in an animal model. The aim of this randomized, double-blind, versus placebo study is to assess this action on experimental gingivitis in humans. Over a 14-day period (day 0-day 14), 37 healthy volunteers undertook intensive oral hygiene, and then did not brush their teeth for 21 days (day 14-day 35) so that gingivitis could then develop. On day 28, the subjects were randomized in two groups: 18 in the treatment group (fish oil: 1.8 g of n-3 PUFA), 19 in the placebo group (olive oil), at a daily dose of 6 g over days (day 28-day 35). The Plaque Index (PI), the Gingival Index (GI) and the Papilla Bleeding Index (PBI), as inflammation markers, were measured on day 14, day 28 and day 35. On day 28 and day 35, five volunteers of each group underwent removal of an interdental papilla to carry out the n-3 PUFA composition of cell membranes: arachidonic acid (AA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), docosahexaenoic acid (DHA). The results show the integration of EPA, DHA and DPA in the membranes of the cells removed and particularly a significant increase of EPA in the treatment group (p = 0.04 S). GI in the treatment group decreased significantly (p = 0.008 S). The level of AA decrease, but no significantly. It would therefore seem that the n-3 PUFA have an effect on the reduction of gingival inflammation in this experimental gingival model in humans. Publication Types: * Clinical Trial * Randomized Controlled Trial PMID: 8720373 [PubMed - indexed for MEDLINE]